v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 26, 2026
Sep. 27, 2025
Sep. 26, 2026
Sep. 27, 2025
Revenues        
Total revenues $ 12,137 $ 11,122 $ 35,136 $ 32,341
Costs and operating expenses:        
Selling, general and administrative expenses 2,321 2,162 6,835 6,380
Research and development expenses 348 346 1,048 1,041
Restructuring and other costs 199 135 346 316
Total costs and operating expenses 9,874 9,182 28,923 26,850
Operating income 2,263 1,941 6,213 5,491
Interest income 252 234 693 735
Interest expense (417) (347) (1,172) (1,054)
Other income/(expense) (10) (2) 13 (18)
Income before income taxes 2,088 1,826 5,746 5,155
Benefit from/(provision for) income taxes (352) (207) (590) (394)
Equity in earnings/(losses) of unconsolidated entities (9) 2 (32) (9)
Net income 1,727 1,621 5,124 4,751
Less: net income/(loss) attributable to noncontrolling interests and redeemable noncontrolling interest 6 5 16 11
Net income attributable to Thermo Fisher Scientific Inc. $ 1,721 $ 1,616 $ 5,108 $ 4,740
Earnings per share attributable to Thermo Fisher Scientific Inc.        
Basic (in dollars per share) $ 4.65 $ 4.28 $ 13.77 $ 12.55
Diluted (in dollars per share) $ 4.64 $ 4.27 $ 13.75 $ 12.53
Weighted average shares        
Basic (in shares) 370 378 371 378
Diluted (in shares) 371 378 372 378
Segment Reconciling Items        
Revenues        
Total revenues $ 546 $ 503 $ 1,635 $ 1,487
Costs and operating expenses:        
Restructuring and other costs 199 135 346 316
Interest income 252 234 693 735
Interest expense (417) (347) (1,172) (1,054)
Other income/(expense) (10) (2) 13 (18)
Product revenues        
Revenues        
Total revenues 6,753 6,489 19,852 18,719
Costs and operating expenses:        
Cost of revenues 3,338 3,319 10,061 9,683
Service revenues        
Revenues        
Total revenues 5,384 4,633 15,283 13,623
Costs and operating expenses:        
Cost of revenues $ 3,668 $ 3,220 $ 10,633 $ 9,431